Sesen Bio Inc (SESN)

[tob999]

Ummm..in the bank?! This is a NASDAQ stock. The deal with Roche is REAL. Maybe head back to the OTC with the P&D nonsense huh?

Eleven is entitled to receive $30 million in payments from Roche, including a $7.5 million upfront payment in connection with the effectiveness of the license agreement, and a $22.5 million milestone payment based on the Investigational New Drug application (IND) for EBI-031 becoming effective.

Under the terms of the agreement, Eleven could receive up to an additional $240 million upon the achievement of certain future regulatory, development and commercialization milestones. In addition, Eleven could be entitled to receive royalties for net sales of potential future products containing EBI-031 or any other potential future products containing other Eleven IL-6 compounds.

http://ih.advfn.com/p.php?pid=nmona&article=72222654